Sage Journals: Discover world-class research

Abstract

Recent advances in the field of molecular biology have led to a better understanding of the pathological mechanisms of cardiovascular disease. The impact of these findings will shape the future of treatment modalities for cardiovascular disorders. Postulated targets and biological rationale of new techniques are being developed in a race towards molecular therapies for vascular diseases. Whether it is modulation of transmembrane cell receptors or phenotypic changes via vectors that mediate gene transfer, there is no doubt that molecular strategies will be an integral part of the future.

Here we examine past and recent perspectives, describe directions and challenges in cardiac and cardiovascular areas of research, and discuss relevance to the field of cardiovascular perfusion.

Get full access to this article

View all access options for this article.

References

Libby P , Schoen FJ , Pober JS. Arteriosclerosis of cardiac transplantation. In: Haber E ed. Scientific American molecular cardiovascular medicine. New York: Scientific American , 1995: 311-324.

King RC , Stansfield WD. A dictionary of genetics, 5th edition. Oxford: Oxford University Press , 1997.

Alberts B , Bray D , Lewis I , Raff M , Roberts K , Watson ID. Molecular biology of the cell. New York: Garland Publishing , 1994.

Childs B. Introduction. In: Childs B , Holtzman NA , Kazazian HH , Valle DL eds. Molecular genetics in medicine: progress in medical genetics, Vol. 7. New York: Elsevier Scientific , 1988: 1-16.

Valle DL , Mitchell GA. Inborn errors of metabolism in the molecular age. In: Childs B , Holtzman NA , Kazazian HH , Valle DL eds. Molecular genetics in medicine: progress in medical genetics, Vol. 7. New York: Elsevier Scientific , 1988: 100-142.

Childs B , Motuisky AG. Recombinant DNA analysis of multifactorial disease. In: Childs B , Holtzman NA , Kazazian HH , Valle DL eds. Molecular genetics in medicine: progress in medical genetics, Vol. 7. New York: Elsevier Scientific , 1988: 180-194.

Arnhelim N , Erlich HA. Commercial uses of recombinant DNA technology in human genetic disease. In: Childs B , Holtzman NA , Kazazian HH , Valle DL eds. Molecular genetics in medicine: progress in medical genetics, Vol. 7. New York: Elsevier Scientific , 1988: 195-219.

Rosenberg LE: Inborn errors of metabolism. In: Metabolic control and disease. Philadelphia, PA: WB Saunders , 1980: 73-102.

Gibbons GH , Dzau VI. Molecular therapies for vascular diseases . Science 1996; 272: 689-693 .

10.

Keating MT , Sanguinetti, MC. Molecular genetic insights into cardiovascular disease . Science 1996; 272: 681-685 .

11.

Barinaga M. Gene therapy for clogged arteries passes test in pigs . Science 1994; 265: 738-738 .

12.

von der Leyen HE , Mann MI , Dzau VI. Gene therapy of cardiovascular disorders. In: Alexander RW , Schlant RC , Fuster V , O’Rourke RA , Robert R , Sonnenblick, EH eds. Hurst’s The Heart, 9th edition. New York: McGraw-Hill , 1998: 213-225.

13.

Nabel EG , Pompili VI , Plautz GE , Nabel GJ. Gene transfer and vascular disease . Cardiovascular Research 1994; 28: 445-455 .

14.

Rowland RT , Cleveland JC , Xianzhong M , Harken AH , Broen JM. Potential gene therapy strategies in the treatment of cardiovascular disease . Ann Thorac Surg 1995; 60: 721-728 .

15.

Li K , Buvoli M , Welikson RE , Vikstrom KL , Leinwand LA. Advances in cardiovascular gene transfer . Cardiologia 1997; 42: 39-46 .

16.

Shih HT. Anatomy of the action potential in the heart . Texas Heart Institute J 1994; 21: 30-41 .

17.

Marian AJ , Roberts R. Molecular basis of hypertrophic and dilated cardiomyopathy . Texas Heart Institute J 1994; 21: 6-15 .

18.

Vanhoutte PM , Scott-Burden T. The endothelium in health and disease . Texas Heart Institute J 1994; 21: 62-67 .

19.

Ballantyne CM , Chan L , Morrisett ID , Mims MP , Gotto AM. Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine . Texas Heart Institute J 1994; 21: 48-55 .

20.

Casscells W , Engler D , Willerson IT. Mechanisms of restenosis . Texas Heart Institute J 1994; 21: 68-77 .

21.

Majesky MW. Neointima formation after acute vascular injury: role of counter adhesive extracellular matrix proteins . Texas Heart Institute J 1994; 21: 78-85 .

22.

Scott-Burden T , Vanhoutte PM. Regulation of smooth muscle cell growth by endothelium-derived factors . Texas Heart Institute J 1994; 21: 91-97 .

23.

Haber E. The impact of molecular biology on cardiovascular medicine. In: Haber E ed. Scientific American molecular cardiovascular medicine. New York: Scientific American , 1995: 1-10.

24.

Ross R. Arteriosclerosis, an overview. In: Haber E ed. Scientific American molecular cardiovascular medicine. New York: Scientific American , 1995: 11-30.

25.

Kneger M. Lipoprotein receptors and atherosclerosis. In: Haber E ed. Scientific American molecular cardiovascular medicine. New York: Scientific American , 1995: 31-47.

26.

Klagsbrun M. Vascular cell growth factors and the arterial wall. In: Haber E ed. Scientific American molecular cardiovascular medicine. New York: Scientific American , 1995: 63-78.

27.

Nabel EG , Nabel GJ. Gene therapy for cardiovascular disease. In: Haber E ed. Scientjfic American molecular cardiovascular medicine. New York: Scientific American , 1995: 79-96.

28.

Zak R. Molecular mechanisms of cardiac hypertrophy. In: Haber E ed. Scientfic American molecular cardiovascular medicine. New York: Scientific American , 1995: 177-192.

29.

Seidman CE , Seidman JG. Gene mutations that cause familial hypertrophic cardiomyopathy. In: Haber E ed. Scientific American molecular cardiovascular medicine. New York: Scientific American , 1995: 193-209.

30.

Fozzard HA. Ion channels and cardiac function. In: Haber E ed. Scientific American molecular cardiovascular medicine. New York: Scientific American , 1995: 211-224.

31.

Chien KR , Shimizu M , Hoshijima M , Minamisawa S , Grace AA. Toward molecular strategies for heart disease: past, present, future . Jpn Circ J 1997; 61: 91-118 .

32.

Gibbons GH , Dzau VJ. The emerging concept of vascular remodeling . New Engl J Med 1994; 330: 1431-1438 .

33.

Gimbrone MA. Vascular endothelium in health and disease. In: Haber E ed. Scientific American molecular cardiovascular medicine. New York: Scientific American , 1995: 49-62.

34.

Gibbons GH. Endothelial function as a determinant of vascular function and structure: a new therapeutic target . Am J Cardiol 1997; 79: 3-8 .

35.

Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s . Nature 1993; 362: 801-809 .

36.

Geary RL , Clowes AW , Lau S et al. Gene transfer in baboons using prosthetic vasular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy . Hum Gene Ther 1994: 10; 1211-1216 .

37.

Asahara T , Bauters C , Pastore C et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured carotid artery . Circ 1995; 91: 2793-2801 .

38.

Isner IM , Walsh K , Symes I et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease . Circ 1995; 91: 2687-2692 .

39.

von der Leyen HE , Gibbons GH , Morishita R et al. Gene therapy inhibiting neointimal vascular lesion: in vivo gene transfer of endothelial-cell nitric oxide synthase gene . Proc Natl Acad Sci USA 1995; 92: 1137-1141 .

40.

Motuisky AG. The 1985 Nobel Prize in physiology or medicine . Science 1986; 231: 126-126 .

41.

Milewicz DM. Identification of defects in the fibrillin gene and protein in individuals with the Marfan Syndrome and related disorders . Texas Heart Institute J 1994; 21: 22-29 .

42.

Miller AD. Human gene therapy comes of age . Nature 1992; 357: 455-460 .

43.

Anderson WF. Gene therapy . Sci Am 1995: 124-127 .

44.

Crystal RG. Transfer of genes to humans: early lessons and obstacles to success . Science 1995; 270: 404-410 .

45.

Anderson WF. Human gene therapy . Science 1992; 256: 808-813 .

46.

Schneider MD , French BA. The advent of adenovirus. Gene therapy for cardiovascular disease . Circulation 1993; 88: 1937-1942 .

47.

Wu KK , Zoldhelyi P , Willerson IT , Xu XM , Loose-Mitchell, DS , Wang LH. Gene therapy for vascular diseases . Texas Heart Institute J 1994; 21: 98-103 .

48.

Mulligan RC. The basic science of gene therapy . Science 1993; 260: 926-932 .

49.

Mazur W , Ali NM , Raizner AE , French BA. Coronary restenosis and gene therapy . Texas Heart Institute J 1994; 21: 104-111 .

50.

Brown IM , Harken AH , Sharefkin JB. Recombinant DNA and surgery . Ann Surg 1990; 212: 178-186 .

51.

Breslow IL. Mouse models of atherosclerosis . Science 1996; 272: 685-688 .

52.

Stone NJ. Secondary causes of hyperlipidemia . Med Clinics of North Am 1994; 78: 117-141 .

53.

Nabel EG , Plautz G , Boyce FM et al. Recombinant gene expression in vivo within endothelial cells of the arterial wall . Science 1989; 244: 1342-1344 .

54.

Isner JM , Feldman LJ. Gene therapy for arterial disease . Lancet 1994; 344: 1653-1654 .

55.

Mann MJ , Gibbons GH , Tsao PS et al. Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts . J Clin Invest 1997; 99: 1295-1301 .

56.

Mann MJ , Gibbons GH , Kernoff RS et al. Genetic engineering of vein grafts resistant to atherosclerosis . Proc Natl Acad Sci USA 1995: 92: 4502-4516 .

57.

Simons M , Edelman ER , DeKeyser JL et al. Antisense c-myboligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo . Nature 1992; 359; 67-70 .

58.

Ohno T , Gordon D , San H et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury . Science 1994; 265: 781-784 .

59.

Nabel EG , Plautz G , Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall . Science 1990; 249: 1285-1288 .

60.

Dichek DA , Neville RF , Zwiebel JA et al. Seeding of intravascular stents with genetically engineered endothelial cells . Circ 1989; 80: 1347-1353 .

61.

Folkman J. Tumor angiogenesis: therapeutic implications . N Engl J Med 1971; 285: 1182-1186 .

62.

Folkman J. Angiogenic therapy of the human heart . Circ 1998; 97: 628-629 .

63.

Baumgartner I , Pieczek A , Manor O et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia . Circ 1998; 97: 1114-1123 .

64.

Isner JM , Pieczek A , Schaninfeld R et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patients with ischaemic limb . Lancet 1996; 348: 370-374 .

65.

Schumacher B , Pecher P , von Specht BU , Stegmann TH. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical trials of a new treatment of coronary heart disease . Circ 1998; 97: 645-650 .

66.

Magovern CJ , Mack CA , Zhang J et al. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector . Ann Thor Surg 1996; 62: 425-434 .

67.

Mack CA , Patel SR , Schwarz EA et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart . J Thorac Cardiovasc Surg 1998; 115: 168-177 .

68.

Luo Z , Diaco M , Murohara T et al. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury . Ann Thor Surg 1997; 64: 993-998 .

69.

Tschudi MR , Barton M , Beresinger NA et al. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery . J Clin Invest 1996; 98: 899-905 .

70.

Asahara T , Murohara T , Sullivan A et al . Isolation of putative progenitor endothelial cells for angiogenesis . Science 1997; 275: 964-967 .

71.

Rivard A , Isner JM. Angiogenesis and vasculogenesis in treatment of cardiovascular disease . Mol Med 1998; 4: 429-440 .

72.

Nabel EG. Gene therapy for vascular diseases . Atherosclerosis 1995; 118: S51-S56 .

73.

Wechsler AS. Molecular biology 101 . Ann Thorac Surg 1995; 60: 497-498 .

74.

Barr E , Lin H , Boiling SF et al. Induction of angiogenesis following in vivo gene transfer into myocardium . Circulation 1991; 84: 420-420 .

75.

Barr E , Tripathy SK , Kozarsky K et al. PCGT, catheter-based gene transfer into the heart using replication-deficient recombinant adenoviruses . J Cell Biochem 1993; 17: 195-195 .

76.

Chapman GD , Lim CS , Gammon RS et al. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter . Circ Res 1992; 71: 27-33 .

77.

Chien KR. Molecular advances in cardiovascular biology . Science 1993; 260: 916-917 .

78.

Chien KR. Molecular basis of cardiovascular disease: a companion to Braunwald’s heart disease. Philadelphia, PA: WB Saunders , 1999.

79.

Kaplitt MG , Xial X , Samuiski RJ et al. Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus . Ann Thorac Surg 1996; 62: 1669-1676 .

80.

Leinwand LA , Leiden JM. Gene transfer into cardiac myocytes in vivo . Trends Cardiovasc Med 1991; 1: 271-276 .

81.

Lifton RP. Molecular genetics of human blood pressure variation . Science 1996; 272: 676-680 .

82.

Olson EN , Srivastava D. Molecular pathways controlling heart development . Science 1996; 272: 671-676 .

83.

Schneider MD , MacLellan R , Kirshenvaurn LA , Brand T. Molecular approaches to cardiac development and hypertrophy . Texas Heart Institute J 1994; 21: 2-5 .

84.

Wilson JM , Birinyi LK , Salomon RN et al. Implantation of vascular grafts lined with genetically modified endothelial cells . Science 1989; 244: 1344-1346 .

85.

Yanagisawa-Miwa A , Uchida Y , Nakamura F et al. Salvage of infarcted myocardium by angiogenic action of fibroblast growth factor . Science 1992; 257: 1401-1403 .

86.

Yla-Herttula S. Vascular gene transfer . Curr Opin in Lipidology 1997; 8: 72-76 .

Molecular advances in cardiac and cardiovascular disease

Abstract

Get full access to this article

References